Literature DB >> 31917380

Molecular mechanism with regard to the binding selectivity of inhibitors toward FABP5 and FABP7 explored by multiple short molecular dynamics simulations and free energy analyses.

Jianzhong Chen1, Xinguo Liu2, Shaolong Zhang2, Junxiao Chen3, Haibo Sun1, Lin Zhang4, Qinggang Zhang2.   

Abstract

Recently, fatty acid binding proteins 5 and 7 (FABP5 and FABP7) have been regarded as the prospective targets for clinically treating multiple diseases related to FABPs. In this work, multiple short molecular dynamics (MSMD) simulations followed by binding free energy calculations were performed to investigate the binding selectivity of three inhibitors, namely, 65X, 8KS, and 5M8 toward FABP5 and FABP7. The RMSF analysis suggests that the structural flexibility of FABP5 is stronger than that of FABP7; moreover, the calculated molecular surface area of FABP5 is also larger than that of FABP7. Meanwhile, the results from the cross-correlation analysis show that the inhibitor bindings exert different impacts on the internal dynamics of FABP5 and FABP7. Binding free energies predicted by the molecular mechanics/generalized Born surface area (MM-GBSA) method indicate that the increase in the enthalpy changes caused by the bindings of inhibitors toward FABP7 relative to FABP5 mostly drives the binding selectivity of the inhibitors toward FABP5 versus FABP7. Hierarchical clustering analysis based on the energy contributions of separate residues and calculations of residue-based free energy decompositions were carried out by using the equilibrated MSMD trajectories. The obtained results not only recognize the hot interaction spots of inhibitors with FABP5 and FABP7, but also display that several common residues, namely, (T56, T54), (L60, F58), (E75, E73), (A76, A78), (D79, D77), (R81, R79), (R107, R109), (C120, L118), and (R129, R127) belonging to (FABP5, FABP7) induce obvious binding differences in the inhibitors toward FABP5 and FABP7. Therefore, these residues play significant roles in the binding selectivities of inhibitors toward FABP5 and FABP7.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31917380     DOI: 10.1039/c9cp05704h

Source DB:  PubMed          Journal:  Phys Chem Chem Phys        ISSN: 1463-9076            Impact factor:   3.676


  6 in total

1.  Identification of new BACE1 inhibitors for treating Alzheimer's disease.

Authors:  Pragya Kushwaha; Vineeta Singh; Pallavi Somvanshi; Tulika Bhardwaj; George E Barreto; Ghulam Md Ashraf; Bhartendu Nath Mishra; Rajendra Singh Chundawat; Shafiul Haque
Journal:  J Mol Model       Date:  2021-01-30       Impact factor: 1.810

2.  In Silico Identification of Novel Interactions for FABP5 (Fatty Acid-Binding Protein 5) with Nutraceuticals: Possible Repurposing Approach.

Authors:  Ricardo Cabezas; Amirhossein Sahebkar; Valentina Echeverria; Janneth González Santos; Ghulam Md Ashraf; George E Barreto
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Theoretical exploration of the binding selectivity of inhibitors to BRD7 and BRD9 with multiple short molecular dynamics simulations.

Authors:  Lifei Wang; Yan Wang; Juan Zhao; Yingxia Yu; Nianqian Kang; Zhiyong Yang
Journal:  RSC Adv       Date:  2022-06-06       Impact factor: 4.036

4.  Multiple Molecular Dynamics Simulations and Energy Analysis Unravel the Dynamic Properties and Binding Mechanism of Mutants HIV-1 Protease with DRV and CA-p2.

Authors:  Ruige Wang; Qingchuan Zheng
Journal:  Microbiol Spectr       Date:  2022-03-23

5.  Binding Selectivity of Inhibitors toward Bromodomains BAZ2A and BAZ2B Uncovered by Multiple Short Molecular Dynamics Simulations and MM-GBSA Calculations.

Authors:  Lifei Wang; Yan Wang; Zhiyong Yang; Shuobo Xu; Hongyun Li
Journal:  ACS Omega       Date:  2021-04-28

6.  Binding selectivity of inhibitors toward the first over the second bromodomain of BRD4: theoretical insights from free energy calculations and multiple short molecular dynamics simulations.

Authors:  Yan Wang; Shiliang Wu; Lifei Wang; Zhiyong Yang; Juan Zhao; Lulu Zhang
Journal:  RSC Adv       Date:  2020-12-24       Impact factor: 3.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.